Design and Validation of a New Assessment Tool for Lichen Planopilaris
1 other identifier
observational
40
1 country
1
Brief Summary
The study's Primary Objective is to design and validate a grading system for objective and accurate assessment of lichen planopilaris. Secondary Objectives:
- To assess change in symptoms such as pain and itch using a Numeric Rating Scale(NRS) scores and quality of life using the Dermatology Life Quality Index (DLQI) scores
- To correlate this grading system with patient skin biopsies evaluating disease activity on a microscopic level
- To correlate this grading system with digital global photography and trichoscopy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2017
CompletedFirst Submitted
Initial submission to the registry
March 13, 2017
CompletedFirst Posted
Study publicly available on registry
March 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJanuary 26, 2022
January 1, 2022
3.6 years
March 13, 2017
January 24, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)
Design and validate a grading system for objective and accurate assessment of lichen planopilaris.
6 months
Study Arms (1)
Group 1
Healthy adult patients with lichen planopilaris
Interventions
A clinical assessment tool to objectively and accurately measure activity and severity in lichen planopilaris over time.
Eligibility Criteria
Healthy adult subjects with lichen planopilaris
You may qualify if:
- Male or female subjects in general good health between the ages of 18 and 80 years old
- Clinical and histologic diagnosis of lichen planopilaris
- Subject is able to understand and sign informed consent
- Subject is able to complete the study and comply with study procedures
- Subject has no known allergy to non-toxic ink
- Subjects should be managed by an Massachusetts General Hospital dermatologist for their lichen planopilaris for the duration of the study
You may not qualify if:
- Eligible subjects will be excluded from participation if they meet any of the following criteria:
- Presence of dermatoses that might interfere with LPP diagnosis and/or evaluation such as seborrheic dermatitis or psoriasis
- Other selected concomitant causes of hair loss, including discoid lupus erythematosus, central centrifugal cicatricial alopecia (CCCA), telogen effluvium
- Abnormal TSH laboratory value \>1 standard deviation above normal within last year
- Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
- Any known allergy to non-toxic ink Related to Biopsy
- History of poor wound healing or blood-clotting abnormality
- History of keloid formation or hypertrophic scarring
- Regular intake of high doses of aspirin or anti-coagulant medications
- Hypersensitivity to local anesthetics
- History of poorly controlled diabetes mellitus
- Pregnant, nursing or planning a pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maryanne Senna, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dermatologist
Study Record Dates
First Submitted
March 13, 2017
First Posted
March 17, 2017
Study Start
February 10, 2017
Primary Completion
September 11, 2020
Study Completion
December 1, 2022
Last Updated
January 26, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share